ICGT ICG Enterprise Trust

Hardman & Co Q&A on ICG Enterprise Trust: 1H’23 results – strong half year resilient outlook

Hardman & Co Research
Hardman & Co Q&A on ICG Enterprise Trust: 1H’23 results – strong half year resilient outlook

30-Nov-2022 / 08:00 GMT/BST

Analyst interview | Investment Companies

Q&A with Mark Thomas on ICG Enterprise Trust plc |

1H’23 results – strong half year resilient outlook

Mark provides us with a summary of his report ‘’ explains how the underlying companies are doing, the metrics and results and in the uncertain world we live in what defensive growth as a strategy actually means in practice.

 

ICG Enterprise is a leading listed private equity investor focused on creating long-term growth by delivering consistently strong returns through selectively investing in profitable private companies, primarily in Europe and the US.

 

Listen to the interview

 

If you are interested in meeting the company, you can register your interest

To contact us:

Hardman & Co
1 Frederick's Place

London

EC2R 8AE

Follow us on Twitter @HardmanandCo

Analyst:

Mark Thomas



+44 (0)203 693 7075

 



 

Hardman & Co Research can still be accessed for free after MiFID II. Please to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
End of Announcement - EQS News Service

1500909  30-Nov-2022 

fncls.ssp?fn=show_t_gif&application_id=1500909&application_name=news&site_id=research_pool
EN
30/11/2022

Underlying

ICGTICG Enterprise Trust

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ICG Enterprise Trust

 PRESS RELEASE
Free
ICGT ICG Enterprise ...

Director/PDMR Shareholding

Director/PDMR Shareholding ICG Enterprise Trust plc (the “Company”) 2 April 2026 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them The Company received notification on 1 April 2026 that Jane Tufnell, Chair, transferred 13,283 ordinary shares in the Company ("Shares") from a General Investment Account (“GIA”) to an Individual Savings Account (“ISA”), and that she transferred 6,380 Shares to a person closely associated (“PCA”) with her, who subsequently transferred those 6,380 Shares from a GIA to ...

April 2, 2026 1 EN
Mark Thomas ... (+3)
  • Mark Thomas
  • Martin Hall
  • Mike Foster
ARBB Arbuthnot Banki...
RECI Real Estate Cre... ... (+6)

Hardman & Co Monthly: April 2026

Feature article: 2025 pharma statistics, by Dr Martin Hall, Head of Life Sciences at Hardman & Co Our pharmaceutical dataset has been compiled over 40 years from 109 companies, which, through M&A activity and consolidation, now comprise 46 companies. An efficient reporting system has seen all the listed multinational pharma companies announce results for 2025, giving us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of global pharmac...

ARBB ARBUTHNOT BANKING GROUP
RECI REAL ESTATE CREDIT INVESTMENTS
ACSO ACCESSO TECHNOLOGY GROUP
VTAS VOLTA FINANCE (GBP)
ICGT ICG ENTERPRISE TRUST
A0MXLB NB PRIVATE EQUITY PARTNERS
04/02/26 April 2, 2026 1 EN
 PRESS RELEASE
Free
ICGT ICG Enterprise ...

Voting Rights and Capital

Voting Rights and Capital ICG Enterprise Trust plc (the “Company”) 1 April 2026 Total Voting Rights In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company announces as follows. At the close of business on 31 March 2026, the Company had 63,554,192 Ordinary shares in issue, of which 2,074,106 were held in Treasury. Therefore, the total number of voting rights in the Company is 61,480,086.The above figure 61,480,086 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their intere...

April 1, 2026 1 EN
 PRESS RELEASE
Free
ICGT ICG Enterprise ...

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 31 March 2026 Transaction in Own Shares The Company announces that on 30 March 2026 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1330 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 2,089,106Total shares in issue excluding treasury shares following settlement of this purchase: 61,465,086 The Company has bought back these shares under the authority granted by shareholders at i...

March 31, 2026 1 EN
 PRESS RELEASE
Free
ICGT ICG Enterprise ...

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 25 March 2026 Transaction in Own Shares The Company announces that on 24 March 2026 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1327 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 2,074,106Total shares in issue excluding treasury shares following settlement of this purchase: 61,480,086 The Company has bought back these shares under the authority granted by shareholders at its Annual Ge...

March 25, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch